PS: "The stock tanked after news came out that the secondary end points were not met". Interesting interpretation . What actually happened was a dramatic spike in the stock price after the P2 results were announced (it went from about $2 - where it had been for about 5-6 months - to $6), followed by a retrace back to about $3 a few weeks later. Typical biotech volatility - not sure how anyone could draw any meaningful interpretations from that.
PS: "The stock tanked after news came out that the secondary end...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3418 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 24361 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |